Skip to main content
. 2015 Sep 15;8(9):15173–15181.

Table 1.

General data of DLBCL patients and healthy controls

Healthy individuals DLBCL patients
Age (year) 61 (20-80) 60 (21-80)
Gender 15 (50.0%) for male 75 (52.1%) for male
Histological subtype
    R-IPI (GCB-DLBCL)
        Very good prognosis (0) 9 (6.3%)
        Good prognosis (1, 2) 27 (18.8%)
        Poor prognosis (3, 4, 5) 27 (18.8%)
    R-IPI (non-GCB-DLBCL)
        Very Good prognosis (0) 12 (8.3%)
        Good prognosis (1, 2) 30 (20.8%)
        Poor prognosis (3, 4, 5) 39 (27.1%)
    MΦ (%) (GCB-DLBCL)
        <0.08 0.06±0.011 24 (16.7%)
        ≥0.08 0.09±0.010 39 (27.1%)
    MΦ (%) (non-GCB-DLBCL)
        <0.08 0.07±0.007 27 (18.8%)
        ≥0.08 0.12±0.042 54 (37.5%)
    MΦ (%)
        <0.08 0.05±0.016 (27 (90.0%))
        ≥0.08 0.08±0.00 (3 (10.0%))